BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12644003)

  • 1. Leukemia inhibitory factor is augmented in the heart in experimental heart failure.
    Jougasaki M; Leskinen H; Larsen AM; Cataliotti A; Chen HH; Burnett JC
    Eur J Heart Fail; 2003 Mar; 5(2):137-45. PubMed ID: 12644003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial gene expression of leukaemia inhibitory factor, interleukin-6 and glycoprotein 130 in end-stage human heart failure.
    Eiken HG; Øie E; Damås JK; Yndestad A; Bjerkeli V; Aass H; Simonsen S; Geiran OR; Tønnessen T; Christensen G; Frøland SS; Gullestad L; Attramadal H; Aukrust P
    Eur J Clin Invest; 2001 May; 31(5):389-97. PubMed ID: 11380590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmented cardiac cardiotrophin-1 in experimental congestive heart failure.
    Jougasaki M; Tachibana I; Luchner A; Leskinen H; Redfield MM; Burnett JC
    Circulation; 2000 Jan 4-11; 101(1):14-7. PubMed ID: 10618298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of cardiotrophin-1 during ventricular remodeling in hypertensive rats.
    Takimoto Y; Aoyama T; Iwanaga Y; Izumi T; Kihara Y; Pennica D; Sasayama S
    Am J Physiol Heart Circ Physiol; 2002 Mar; 282(3):H896-901. PubMed ID: 11834484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cardiac adrenomedullin in heart failure.
    Jougasaki M; Grantham JA; Redfield MM; Burnett JC
    Peptides; 2001 Nov; 22(11):1841-50. PubMed ID: 11754971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of omapatrilat on cardiac nerve sprouting and structural remodeling in experimental congestive heart failure.
    Cha YM; Redfield MM; Shah S; Shen WK; Fishbein MC; Chen PS
    Heart Rhythm; 2005 Sep; 2(9):984-90. PubMed ID: 16171755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of sustained atrial tachycardia in dogs with rapid ventricular pacing-induced heart failure.
    Stambler BS; Fenelon G; Shepard RK; Clemo HF; Guiraudon CM
    J Cardiovasc Electrophysiol; 2003 May; 14(5):499-507. PubMed ID: 12776867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure.
    Luchner A; Stevens TL; Borgeson DD; Redfield M; Wei CM; Porter JG; Burnett JC
    Am J Physiol; 1998 May; 274(5):H1684-9. PubMed ID: 9612380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional significance of hemodynamic overload-induced expression of leukemia-inhibitory factor in the adult mammalian heart.
    Wang F; Seta Y; Baumgarten G; Engel DJ; Sivasubramanian N; Mann DL
    Circulation; 2001 Mar; 103(9):1296-302. PubMed ID: 11238276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure.
    Hanna N; Cardin S; Leung TK; Nattel S
    Cardiovasc Res; 2004 Aug; 63(2):236-44. PubMed ID: 15249181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine-induced expression of leukemia inhibitory factor in renal mesangial cells.
    Hartner A; Sterzel RB; Reindl N; Hocke GM; Fey GH; Goppelt-Struebe M
    Kidney Int; 1994 Jun; 45(6):1562-71. PubMed ID: 7933804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of leukemia inhibitory factor mRNA and protein by malignant and immortalized bone cells.
    Marusić A; Kalinowski JF; Jastrzebski S; Lorenzo JA
    J Bone Miner Res; 1993 May; 8(5):617-24. PubMed ID: 8511989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human carcinoma cell lines produce biologically active leukemia inhibitory factor (LIF).
    Kamohara H; Sakamoto K; Ishiko T; Mita S; Masuda Y; Abe T; Ogawa M
    Res Commun Mol Pathol Pharmacol; 1994 Aug; 85(2):131-40. PubMed ID: 7994557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive expression of leukemia inhibitory factor (LIF) mRNA and production of LIF by a cloned murine thymic stromal cell line.
    Sakata T; Iwagami S; Tsuruta Y; Yamaguchi M; Michishita M; Nagata K; Takai Y; Ogata M; Teraoka H; Fujiwara H
    Thymus; 1992 Mar; 19(2):89-95. PubMed ID: 1561703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular cardiotrophin-1 activation precedes BNP in experimental heart failure.
    Jougasaki M; Leskinen H; Larsen AM; Luchner A; Cataliotti A; Tachibana I; Burnett JC
    Peptides; 2003 Jun; 24(6):889-92. PubMed ID: 12948841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenomedullin in experimental congestive heart failure: cardiorenal activation.
    Jougasaki M; Stevens TL; Borgeson DD; Luchner A; Redfield MM; Burnett JC
    Am J Physiol; 1997 Oct; 273(4):R1392-9. PubMed ID: 9362304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular systolic performance in failing heart improved acutely by left ventricular reshaping.
    He KL; Shimizu J; Yi GH; Gu A; Kashem MA; Crabbe DL; Popilskis S; Wu EX; Santamore WP; Melvin D; Wang J
    J Thorac Cardiovasc Surg; 2003 Jul; 126(1):56-65. PubMed ID: 12878939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chamber-enriched gene expression profiles in failing human hearts with reduced ejection fraction.
    Luo X; Yin J; Dwyer D; Yamawaki T; Zhou H; Ge H; Han CY; Shkumatov A; Snyder K; Ason B; Li CM; Homann O; Stolina M
    Sci Rep; 2021 Jun; 11(1):11839. PubMed ID: 34088950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemia inhibitory factor (LIF) modulates pro-opiomelanocortin (POMC) gene regulation in stably transfected AtT-20 cells overexpressing LIF.
    Li QL; Yano H; Ren SG; Li X; Friedman TC; Melmed S
    Endocrine; 1997 Dec; 7(3):325-30. PubMed ID: 9657069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis.
    Lotz M; Moats T; Villiger PM
    J Clin Invest; 1992 Sep; 90(3):888-96. PubMed ID: 1522240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.